Duration of a clozapine trial in neuroleptic-resistant schizophrenia.

Suppr

超能文献

作者信息

Meltzer H Y

出版信息

Arch Gen Psychiatry. 1989 Jul;46(7):672. doi: 10.1001/archpsyc.1989.01810070098017.

DOI:10.1001/archpsyc.1989.01810070098017

PMID:2567591

Abstract

摘要

相似文献

Duration of a clozapine trial in neuroleptic-resistant schizophrenia.

Arch Gen Psychiatry. 1989 Jul;46(7):672. doi: 10.1001/archpsyc.1989.01810070098017.

Is clozapine response different in neuroleptic nonresponders vs partial responders?氯氮平对抗精神病药无反应者与部分反应者的反应是否不同？

Arch Gen Psychiatry. 1990 Feb;47(2):189-90. doi: 10.1001/archpsyc.1990.01810140089012.

Clozapine and electroconvulsive therapy.

Arch Gen Psychiatry. 1990 Mar;47(3):290-1. doi: 10.1001/archpsyc.1990.01810150090018.

Clozapine for refractory schizophrenia: an open study of 14 patients treated up to 2 years.氯氮平治疗难治性精神分裂症：14例患者长达2年的开放性研究。

J Clin Psychiatry. 1989 Oct;50(10):389-91.

A review of clozapine: an antipsychotic for treatment-resistant schizophrenia.氯氮平综述：一种用于治疗难治性精神分裂症的抗精神病药物。

Compr Psychiatry. 1990 Jul-Aug;31(4):315-26. doi: 10.1016/0010-440x(90)90038-t.

Clozapine in the treatment of newly admitted schizophrenic patients. A pilot study.氯氮平治疗新入院精神分裂症患者：一项初步研究。

J Clin Pharmacol. 1976 May-Jun;16(5-6):289-97. doi: 10.1002/j.1552-4604.1976.tb02407.x.

[Clozapine and treatment of negative symptoms].[氯氮平与阴性症状的治疗]

Encephale. 1997 Sep;23 Spec No 4:7-11.

Who should receive clozapine?谁应该接受氯氮平治疗？

Arch Gen Psychiatry. 1988 Sep;45(9):865-7. doi: 10.1001/archpsyc.1988.01800330099012.

[Value of neuroleptic therapy in the self assessment of schizophrenic patients].

Psychiatr Neurol Med Psychol (Leipz). 1987 Aug;39(8):487-91.

[Comparison of two antipsychotic drugs: chlorpromazine and clozapine (author's transl)].

Ther Umsch. 1975 Aug;32(8):497-500.

引用本文的文献

Lurasidone Improves Psychopathology and Cognition in Treatment-Resistant Schizophrenia.鲁拉西酮改善治疗抵抗性精神分裂症的精神病理学和认知功能。

J Clin Psychopharmacol. 2020 May-Jun;40(3):240-249. doi: 10.1097/JCP.0000000000001205.

Association of Serotonin Receptor Polymorphisms With Antipsychotic Drug Response in Schizophrenia.精神分裂症中血清素受体多态性与抗精神病药物反应的关联。

Front Psychiatry. 2019 Feb 15;10:58. doi: 10.3389/fpsyt.2019.00058. eCollection 2019.

Significant weight loss following clozapine use, how is it possible? A case report and review of published cases and literature relevant to the subject.使用氯氮平后出现显著体重减轻，这怎么可能呢？一例病例报告以及对已发表的相关病例和文献的综述。

Ther Adv Psychopharmacol. 2016 Oct;6(5):335-342. doi: 10.1177/2045125316649534. Epub 2016 May 31.

Gene-expression analysis of clozapine treatment in whole blood of patients with psychosis.精神分裂症患者全血中氯氮平治疗的基因表达分析。

Psychiatr Genet. 2016 Oct;26(5):211-7. doi: 10.1097/YPG.0000000000000140.

Aripiprazole augmentation of clozapine in treatment-resistant schizophrenia: a clinical observation.阿立哌唑增强氯氮平治疗难治性精神分裂症的临床观察

Clin Drug Investig. 2006;26(3):117-24. doi: 10.2165/00044011-200626030-00001.

Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.电休克疗法治疗氯氮平无反应的精神分裂症患者——一项开放性研究。

Eur Arch Psychiatry Clin Neurosci. 2004 Dec;254(6):372-9. doi: 10.1007/s00406-004-0517-y. Epub 2004 Nov 12.

Conventional versus novel antipsychotics: changing concepts and clinical implications.传统抗精神病药物与新型抗精神病药物：概念变迁与临床意义

J Psychiatry Neurosci. 1999 Nov;24(5):431-41.

Myths and mystifications of managed care.

J Ment Health Adm. 1990 Fall;17(2):138-44. doi: 10.1007/BF02521142.

Drug treatment of schizophrenia in the 1990s. Achievements and future possibilities in optimising outcomes.20世纪90年代精神分裂症的药物治疗。优化治疗效果的成就与未来可能性。

Drugs. 1997 Jun;53(6):915-29. doi: 10.2165/00003495-199753060-00002.

Review: treatment of schizophrenia. State of the art.综述：精神分裂症的治疗。当前的技术水平。

Eur Arch Psychiatry Clin Neurosci. 1996;246(5):229-34. doi: 10.1007/BF02190273.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验